Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

GNA13 loss in germinal center B cells leads to impaired apoptosis and promotes lymphoma in vivo

Blood (2016) 127 (22): 2723–2731.

https://doi.org/10.1182/blood-2015-07-659938

Published: 2016

Includes: Supplemental data

Journal Articles

Validating The Prognostic Significance Of FCRL2 In Predicting IGHV Mutation Status, Clinical Disease Progression, and Survival In CLL

Fu Jun Li, MD, PhD, Alan B Cantor, PhD, Mikhail A. Shakhmatov, MD, Ran Li, MD, Xiao-Jie Yan, MD PhD, Nicholas Chiorazzi, MD, Randall S. Davis, MD

Blood (2013) 122 (21): 4140.

https://doi.org/10.1182/blood.V122.21.4140.4140

Published: 2013

Journal Articles

FcRL4 acts as an adaptive to innate molecular switch dampening BCR signaling and enhancing TLR signaling

Hae Won Sohn, Peter D. Krueger, Randall S. Davis, Susan K. Pierce

Blood (2011) 118 (24): 6332–6341.

https://doi.org/10.1182/blood-2011-05-353102

Published: 2011

Includes: Multimedia, Supplemental data

Journal Articles

Enhanced levels of both the membrane-bound and soluble forms of IgM Fc receptor (FcμR) in patients with chronic lymphocytic leukemia

Fu Jun Li, Yoshiki Kubagawa, Matthew K. McCollum, Landon Wilson, Tomoko Motohashi, Luigi F. Bertoli, James C. Barton, Stephen Barnes, Randall S. Davis, Hiromi Kubagawa

Blood (2011) 118 (18): 4902–4909.

https://doi.org/10.1182/blood-2011-04-350793

Published: 2011

Includes: Supplemental data

Journal Articles

IL-12 selectively programs effector pathways that are stably expressed in human CD8 + effector memory T cells in vivo

Fatema Z. Chowdhury, Hilario J. Ramos, Laurie S. Davis, James Forman, J. David Farrar

Blood (2011) 118 (14): 3890–3900.

https://doi.org/10.1182/blood-2011-05-357111

Published: 2011

Includes: Supplemental data

Journal Articles

Histidine-rich glycoprotein: the Swiss Army knife of mammalian plasma

Ivan K. H. Poon, Kruti K. Patel, David S. Davis, Christopher R. Parish, Mark D. Hulett

Blood (2011) 117 (7): 2093–2101.

https://doi.org/10.1182/blood-2010-09-303842

Published: 2011

Journal Articles

Percentage of Smudge Cells Predicting Prognosis In Chronic Lymphocytic Leukemia

Ravikumar Paluri, MD, MPH, Supriya Koya, MD, MBBS, Randall S. Davis, Fun Jun Li, Alan B Cantor, PhD, Vishnu Reddy, MD, Francisco Robert, MD

Blood (2010) 116 (21): 4624.

https://doi.org/10.1182/blood.V116.21.4624.4624

Published: 2010

Journal Articles

FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia

Fu Jun Li, Shouluan Ding, Jicun Pan, Mikhail A. Shakhmatov, Elena Kashentseva, Jiongru Wu, Yufeng Li, Seng-jaw Soong, Nicholas Chiorazzi, Randall S. Davis

Blood (2008) 112 (1): 179–187.

https://doi.org/10.1182/blood-2008-01-131359

Published: 2008

Includes: Supplemental data

Journal Articles

FCRL2 Expression Is Predictive of IgV H Mutation Status and Clinical Progression in Chronic Lymphocytic Leukemia.

Fu Jun Li, MD, PhD, Yufeng Li, PhD, Mikail A. Shakhmatov, MD, Elena Kashentseva, BS, Jiongru Wu, PhD, Laura Z. Rassenti, PhD, Thomas J. Kipps, MD, PhD, Nicholas Chiorazzi, MD, Randall S. Davis, MD

Blood (2007) 110 (11): 488.

https://doi.org/10.1182/blood.V110.11.488.488

Published: 2007

Journal Articles

Arsenic Trioxide with Ascorbic Acid and High-Dose Melphalan for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.

Muzaffar H. Qazilbash, MD, Rima M. Saliba, PhD, Marilyn S. Davis, Floralyn L. Mendoza, Chitra Hosing, MD, Daniel R. Couriel, MD, Marcos De Lima, MD, Partow Kebriaei, MD, Donna M. Weber, MD, Michael Wang, MD, Amin M. Alousi, MD, Steven G. Matthes, Roy B. Jones, MD, PhD, Richard E. Champlin, MD, Sergio A. Giralt, MD

Blood (2006) 108 (11): 3090.

https://doi.org/10.1182/blood.V108.11.3090.3090

Published: 2006

Journal Articles

Childhood Crowding, Atopy and Risk of Non-Hodgkin Lymphoma.

Wendy Cozen, DO, MPH, Engels A. Eric, M.D., M.P.H., James R. Cerhan, M.D., Ph.D., Martha Linet, M.D., M.P.H., Leslie Bernstein, Ph.D., Joanne S. Colt, M.P.H., M.S., Scott S. Davis, Ph.D., M.S., Richard K. Severson, Ph.D., Otoniel Martinez-Maza, Ph.D., Patricia Hartge, Sc.D.

Blood (2006) 108 (11): 4648.

https://doi.org/10.1182/blood.V108.11.4648.4648

Published: 2006

Journal Articles

Arsenic Trioxide with Ascorbic Acid and High-Dose Melphalan: A New Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.

Muzaffar H. Qazilbash, MD, Marilyn S. Davis, Aleman Ana, Linda Roden, Floralyn Libunao, Peter F. Thall, PhD, Xuemei Wang, Daniel Couriel, MD, Marcos De Lima, MD, Chitra Hosing, MD, Partow Kebriaei, MD, Donna Weber, MD, Michael Wang, MD, Roy B. Jones, MD, Ph.D, Steven G. Matthes, Richard E. Champlin, MD, Sergio A. Giralt, MD

Blood (2005) 106 (11): 1159.

https://doi.org/10.1182/blood.V106.11.1159.1159

Published: 2005

Journal Articles

Fixed-Dose Single Agent Pegfilgrastim for Peripheral Blood Progenitor Cell Mobilization in Patients with Multiple Myeloma (MM).

Chitra Hosing, MD, Muzaffar H. Qazilbash, MD, Partow Kebriaei, MD, Sergio Giralt, MD, Marilyn S. Davis, Beverly Rhodes, Veronica Smith, Elizabeth J. Shpall, MD, John McMannis, MD, Martin Korbling, MD, Richard Champlin

Blood (2005) 106 (11): 2923.

https://doi.org/10.1182/blood.V106.11.2923.2923

Published: 2005

Journal Articles

FcRH1: an activation coreceptor on human B cells

Chuen-Miin Leu, Randall S. Davis, Lanier A. Gartland, W. David Fine, Max D. Cooper

Blood (2005) 105 (3): 1121–1126.

https://doi.org/10.1182/blood-2004-06-2344

Published: 2005

Includes: Supplemental data

Journal Articles

Elevated Glomerular Filtration Rate (GFR) in Young Patients with Sickle Cell Anemia.

Sherri A. Zimmerman, MD, Jacqueline S. Davis, RN, MPH, Nicole A. Mortier, MHS, PA-C, Russell E. Ware, MD, PhD

Blood (2004) 104 (11): 3745.

https://doi.org/10.1182/blood.V104.11.3745.3745

Published: 2004

Journal Articles

Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease

Sherri A. Zimmerman, William H. Schultz, Jacqueline S. Davis, Chrisley V. Pickens, Nicole A. Mortier, Thad A. Howard, Russell E. Ware

Blood (2004) 103 (6): 2039–2045.

https://doi.org/10.1182/blood-2003-07-2475

Published: 2004

Journal Articles

Characterization of the phytohemagglutinin-induced proliferating lymphocyte subpopulations in chronic lymphocytic leukemia patients using a clonogenic agar technique and monoclonal antibodies

S Davis

Blood (1981) 58 (5): 1053–1055.

https://doi.org/10.1182/blood.V58.5.1053.1053

Published: 1981

Journal Articles

Lactic dehydrogenase in normal and leukemia lymphocyte subpopulations: evidence for the presence of abnormal T cells and B cells in chronic lymphocytic leukemia

P Rambotti, S Davis

Blood (1981) 57 (2): 324–327.

https://doi.org/10.1182/blood.V57.2.324.324

Published: 1981

Journal Articles

Mitogen stimulation of chronic lymphocytic leukemic lymphocytes: defective phytohemagglutinin stimulation independent of immunologic cell surface markers

S Davis, P Rambotti

Blood (1980) 56 (2): 256–261.

https://doi.org/10.1182/blood.V56.2.256.256

Published: 1980

Journal Articles

Further characterization of the circulating cell in chronic lymphocytic leukemia

EF Schultz, S Davis, AD Rubin

Blood (1976) 48 (2): 223–234.

https://doi.org/10.1182/blood.V48.2.223.223

Published: 1976

NARROW

GNA13 loss in germinal center B cells leads to impaired apoptosis and promotes lymphoma in vivo

Validating The Prognostic Significance Of FCRL2 In Predicting IGHV Mutation Status, Clinical Disease Progression, and Survival In CLL

FcRL4 acts as an adaptive to innate molecular switch dampening BCR signaling and enhancing TLR signaling

Enhanced levels of both the membrane-bound and soluble forms of IgM Fc receptor (FcμR) in patients with chronic lymphocytic leukemia

IL-12 selectively programs effector pathways that are stably expressed in human CD8 + effector memory T cells in vivo

Histidine-rich glycoprotein: the Swiss Army knife of mammalian plasma

Percentage of Smudge Cells Predicting Prognosis In Chronic Lymphocytic Leukemia

FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia

FCRL2 Expression Is Predictive of IgV H Mutation Status and Clinical Progression in Chronic Lymphocytic Leukemia.

Arsenic Trioxide with Ascorbic Acid and High-Dose Melphalan for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.

Childhood Crowding, Atopy and Risk of Non-Hodgkin Lymphoma.

Arsenic Trioxide with Ascorbic Acid and High-Dose Melphalan: A New Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.

Fixed-Dose Single Agent Pegfilgrastim for Peripheral Blood Progenitor Cell Mobilization in Patients with Multiple Myeloma (MM).

FcRH1: an activation coreceptor on human B cells

Elevated Glomerular Filtration Rate (GFR) in Young Patients with Sickle Cell Anemia.

Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease

Characterization of the phytohemagglutinin-induced proliferating lymphocyte subpopulations in chronic lymphocytic leukemia patients using a clonogenic agar technique and monoclonal antibodies

Lactic dehydrogenase in normal and leukemia lymphocyte subpopulations: evidence for the presence of abnormal T cells and B cells in chronic lymphocytic leukemia

Mitogen stimulation of chronic lymphocytic leukemic lymphocytes: defective phytohemagglutinin stimulation independent of immunologic cell surface markers

Further characterization of the circulating cell in chronic lymphocytic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only